Advertisement

Topics

Ebixa Company Profile

03:44 EST 11th December 2018 | BioPortfolio

Ebixa is an effective, safe and well tolerated therapy, that helps overcome the everyday challenges in Alzheimer’s disease, easing the lives of both patients and their carers. Ebixa is indicated for the treatment of moderate to severe Alzheimer’s disease. Ebixa is a specific, uncompetitive NMDA-receptor antagonist, with a novel mechanism of action that targets the glutamatergic signalling in the brain.

Location

H. Lundbeck A/S Ottiliavej 9
Copenhagen
Valby
DK 2500
Denmark

Contact

Phone: 45 36 30 13 11
Fax: 45 36 30 19 40
Email: information@lundbeck.com


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Study in Healthy Subjects to Compare Two Tablet Formulations of Memantine (Ebixa®) in Fasted and Fed Conditions

The purpose of this study is to investigate the release of memantine into the bloodstream of two different formulations: one formulation containing lactose and one without lactose.

Efficacy Study of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism.

The aim of the present study was to examine the influence of memantine, a noncompetitive NMDA receptor blocker, in depression co-morbid with long term alcohol heavy use comparing to SSRI-i...

Memantine for Disability in Amyotrophic Lateral Sclerosis (MEDALS)

The purpose of this trial is to study the effect of Memantine (uncompetitive, moderate affinity, NMDA receptor antagonist that binds to the NMDA receptor channel, and regulates the calciu...

Companies [1 Associated Companies listed on BioPortfolio]

Ebixa

Ebixa is an effective, safe and well tolerated therapy, that helps overcome the everyday challenges in Alzheimer’s disease, easing the lives of both patients and their carers. Ebixa is indicated for...

More Information about "Ebixa" on BioPortfolio

We have published hundreds of Ebixa news stories on BioPortfolio along with dozens of Ebixa Clinical Trials and PubMed Articles about Ebixa for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ebixa Companies in our database. You can also find out about relevant Ebixa Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...


Corporate Database Quicklinks



Searches Linking to this Company Record